New York Life Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Buy |
51,393
+214
| +0.4% | +$86.8K | 0.2% | 100 |
|
|
2025
Q1 | $25.5M | Sell |
51,179
-155
| -0.3% | -$77.1K | 0.26% | 72 |
|
|
2024
Q4 | $26.7M | Buy |
51,334
+473
| +0.9% | +$246K | 0.26% | 70 |
|
|
2024
Q3 | $31.5M | Sell |
50,861
-1,651
| -3% | -$1.02M | 0.31% | 60 |
|
|
2024
Q2 | $29M | Sell |
52,512
-344
| -0.7% | -$190K | 0.29% | 61 |
|
|
2024
Q1 | $30.7M | Sell |
52,856
-2,017
| -4% | -$1.17M | 0.31% | 60 |
|
|
2023
Q4 | $29.1M | Sell |
54,873
-9,227
| -14% | -$4.9M | 0.3% | 62 |
|
|
2023
Q3 | $32.4M | Sell |
64,100
-901
| -1% | -$456K | 0.35% | 51 |
|
|
2023
Q2 | $33.9M | Buy |
65,001
+4,410
| +7% | +$2.3M | 0.35% | 50 |
|
|
2023
Q1 | $34.9M | Sell |
60,591
-168
| -0.3% | -$96.8K | 0.39% | 47 |
|
|
2022
Q4 | $33.5M | Sell |
60,759
-699
| -1% | -$385K | 0.38% | 44 |
|
|
2022
Q3 | $31.2M | Sell |
61,458
-2
| -0% | -$1.01K | 0.38% | 49 |
|
|
2022
Q2 | $33.4M | Buy |
+61,460
| New | +$33.4M | 0.39% | 47 |
|
|
2015
Q2 | – | Sell |
-2,642
| Closed | -$355K | – | 272 |
|
|
2015
Q1 | $355K | Buy |
2,642
+656
| +33% | +$88.1K | 0.04% | 138 |
|
|
2014
Q4 | $249K | Buy |
+1,986
| New | +$249K | 0.03% | 164 |
|